NMC Health Plc Additional Board Disclosures (8787J)

TIDMNMC

RNS Number : 8787J

NMC Health Plc

16 April 2020

NMC Health plc

("NMC PLC" or the "Company")

Additional board disclosures

London - April 16, 2020 - Further to the Company's announcement on April 14, 2020 regarding the appointments of Eli Chahin, Christopher Hall, Myles Halley and Philip Gore-Randall as non-executive Directors of the Company which took effect on April 11, 2020, the Company hereby discloses additional information for the purposes of LR 9.6.13R.

Christopher Hall was a director of MyBucks S.A. (listed on the Frankfurt Stock Exchange) from June 2017 to May 2019.

There is no further information required to be disclosed pursuant to LR 9.6.13R in relation to the appointment of the new non-executive Directors.

ENDS

NOTES TO EDITORS

Media Enquiries

Headland Consultancy

   Susanna Voyle                  +44 7980 894 557 
   Stephen Malthouse           +44 7734 956 201 
   Henry Wallers                   +44 7876 562 436

nmchealthgroup@headlandconsultancy.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNKKABPFBKKOQD

(END) Dow Jones Newswires

April 16, 2020 05:05 ET (09:05 GMT)

Nmc Health (LSE:NMC)
Historical Stock Chart
From Oct 2024 to Nov 2024